Marketing for Regulated Industries: What Changes, What Doesn’t, and How to Win

Marketing for regulated industries follows the same fundamentals as any marketing, but every claim has to be permitted, provable, and presented in a prescribed way, which changes how campaigns are planned, produced, approved, and measured.

If you run a company in financial services, insurance, healthcare, medical devices, or even the animal health pharma space, you already know your marketing operates under rules that companies in other sectors never have to think about. What’s less obvious is how deeply those rules shape the daily mechanics: what your team can say, how long it takes to say it, who can see it, and which channels can carry it.

This is written for the CEO, CMO, or operating partner in a regulated company who wants marketing that grows the business without creating exposure. It covers what changes, what doesn’t, and what to look for in a marketing partner.

The Rules Change. The Job Doesn’t.

Marketing in a regulated company is still marketing. The job is a consistent message and brand, aimed at a specific market, delivered through the channels that matter, in a way that lowers acquisition cost and shortens the buying journey. What regulation adds is a framework to learn and work within. That’s homework, not a different profession.

I hadn’t worked with credit cards until I first worked on a national bank account, and I hadn’t worked in private healthcare insurance until I helped launch the category in the U.K. The fundamentals carried over, the rulebook was extra, though in most cases it isn’t a steep learning curve. It’s also why a partner’s same-industry marketing experience is less relevant than it looks, as long as the rulebook is taken seriously from day one.

The Rulebook Changes by Sector

Every regulated sector has its own set of rules, and knowing which apply is part of the job. A partial map:

Financial services: FINRA (including Rule 2210 on communications), the SEC Marketing Rule, CFPB and UDAAP, Truth in Lending (Reg Z), Truth in Savings (Reg DD), fair lending (ECOA/Reg B), GLBA privacy, FDIC and NCUA advertising requirements, and state regulators.
Insurance: State Departments of Insurance and their filing and review requirements, NAIC model rules, CMS marketing requirements for Medicare Advantage and Part D (via HPMS), ACA rules, and HIPAA.
Medical device: FDA (510(k) and PMA pathways, promotional labeling and advertising rules) and the transparency rules around payments to healthcare professionals.
Animal health: FDA’s Center for Veterinary Medicine, USDA oversight of veterinary biologics, EPA for certain parasiticide products, and the Veterinary Feed Directive in livestock.
Across all of them: FTC advertising rules, TCPA, CAN-SPAM, and a patchwork of state privacy laws.

This list is partial, and rules vary by state and product and change often. Treat it as orientation, and confirm specifics with your own counsel.

What Actually Changes in a Regulated Company

Claims Are Filed Assets, and Approval Has a Calendar

In an unregulated category, “the best value in the market” is a headline. In a regulated one, it can be a liability. Financial communications need context and substantiation. Health insurance materials are held to the plan documents on file. Device and drug promotion must stay within approved or cleared uses and balance benefits with risk. So copy starts with a substantiation file: which claims are approved, what supports each one, and where each can be used.

Time is the second difference, and leaders tend to underestimate it. Earlier in my career, an animal health campaign was approved and ready to launch, and it still sat for a few months waiting on FDA. Geography can matter too. A nationwide insurer of specialized equipment doesn’t operate in a handful of states because of state-specific approval hurdles, which puts an asterisk on “nationwide” and makes where an ad runs part of the compliance conversation.

The answer is forward planning. Work backward from the launch date with review built in, treat approval as a scheduled phase, and keep a contingency campaign ready for the day a launch slips.

Speed Becomes a Design Problem

Teams used to launching, reading the data, and adjusting within days can’t work that way here. The ones that still move quickly design for review instead of fighting it. They pre-approve modular components (headlines, benefit blocks, disclosures, layouts) and assemble campaigns from cleared parts. They bring compliance in at the brief, since rework is the real time cost and early involvement cuts both the timeline and the campaign cost. And they track approval cycle time by asset type, so recurring friction becomes visible and fixable.

Format Is Regulated Too

Required legal language, minimum type sizes, mandated notices, identifiers, and risk information take up space that regular marketing gives to the message. A concept that works as a 15-second video or a small display ad can fall apart once the required language is added.

Design with the constraints from the first sketch. It’s like laying out a newspaper’s front page, where the masthead has to be there. Choose channels that can carry the required content, and let the ad point to a fuller experience rather than trying to say everything at once.

Data, Targeting, and the Envelope

Health, financial, and insurance sites handle sensitive information, and how tracking technologies collect and share data has drawn attention from regulators, courts, and plaintiffs’ attorneys alike. The specifics keep evolving, so the right posture is conservative and built with privacy counsel. In practice that means first-party data, consent-based programs, server-side approaches with tighter controls on what reaches ad platforms, and more reliance on brand tracking and incrementality testing than on pixel-level attribution.

Privacy isn’t only digital, though. My background includes many years in direct mail, where one test matters more than most. It’s called the tap test. You tap the assembled piece on a table and see where everything settles inside the envelope and what shows through the window.

A few years ago, a large national health plan mailed notices to thousands of members about a change in how a particular medication could be filled. The contents shifted inside the envelopes, and wording about a private health condition became visible through the address window. The fallout included a multi-million dollar class action settlement, a fine from a state attorney general, and a pledge to overhaul its processes. The copy itself was fine. The mechanics failed the tap test.

That test takes 10 to 15 seconds with a mock-up. It should happen before files are finalized, and definitely before anything gets near a printer or lettershop.

The same thinking applies to lists. Earlier in my career, I worked on a campaign for a medical device manufacturer that was targeted to people who had reached out to our client asking whether there was a “permanent solution” for their condition. A list like that is sensitive by definition, so the question is never only what the piece says. It’s what anyone else who sees it or handles it can infer.

The Audience Is Rarely a Single Buyer

Almost every regulated category has someone between the brand and the end user: HR and finance leaders and brokers in insurance, advisors in financial services, clinicians in medical devices, veterinarians in animal health. The strongest programs combine push and pull. Push educates the professional through compliant channels. Pull builds awareness with the end user, so the customer arrives already knowing what to ask about.

When a patient, client, or pet owner asks about a specific option by name, the advisor may need to explain why they’re recommending against it, based on other factors that affect the recommendation. That isn’t about putting anyone on the defensive. It makes all parties more aware and leads to better decisions.

Outreach Requires Permission

Consumer protection and privacy laws, including the Telephone Consumer Protection Act and its counterparts, limit how brands can call, text, and email. Opt-in, consent-based lead generation, with the consent documented, is slower to build, but it produces contacts you can actually work with, and it holds up under audit.

What to Look for in a Marketing Partner for a Regulated Company

Whether you’re evaluating an agency, a fractional CMO, or a new hire, these questions show whether someone has built the habits this environment requires:

How do you plan around review timelines? Look for backward planning from the launch date and a contingency plan, not a promised launch date that ignores approvals.
When does compliance enter the process? The right answer is at the brief, not at the finish line.
How do you build creative around required disclosures? Look for answers that start with the constraints, not ones that add them afterward.
How do you measure when tracking is restricted? Strong answers involve first-party data, consent, brand tracking, and incrementality.
How do you handle sensitive lists and physical mail? Someone who’s done this work will have a process, and probably a tap test story.
How will you get up to speed on our specific rules? The honest answer is structured homework and close work with your counsel, not a claim to know everything already.

You don’t need a partner who has memorized your rulebook. You need one who treats your compliance requirements as design inputs, not late-stage obstacles.

Where the Advantage Comes From

If every competitor faces similar products and similar restrictions, differentiation can’t come from bolder claims. It comes from clarity (plain language in categories known for jargon), from experience (how easy it is to get an answer, compare options, or find help), from trust built over time through education and consistent presence outside the buying window, and from operational fluency, meaning a team that ships compliant work quickly and predictably.

Marketing Support for Regulated Companies

indigoOne is a full-service marketing agency and fractional CMO practice for growth-stage and PE-backed companies, and has contributed to client exits totaling $3.5B+ in combined enterprise value. My experience in regulated sectors comes from earlier in my career, including ongoing support of U.S. Bank’s card marketing group, the launch of private healthcare insurance as a category in the U.K., medical device marketing for Augustine Medical (later acquired by 3M Healthcare), and animal health work for Pfizer Animal Health (now Zoetis).

If your marketing is stuck between what you want to say and what you’re allowed to say, let’s talk it through. Book a conversation

Key Takeaways

Marketing for regulated industries follows the same fundamentals as any marketing, but claims must be permitted, provable, and presented in a prescribed way.
The rulebook varies by sector. Treat it as homework to learn and plan around, not a reason to slow down.
Approval timelines are part of the schedule. Plan backward from the launch date and keep a contingency ready.
Modular pre-approved assets and early compliance involvement cut both cycle time and rework.
Privacy covers physical mail as well as digital tracking. Run the tap test on any mailer before files are finalized.
Look for a partner who treats compliance as a design input, and ask how they’ll learn your specific rules.

Frequently Asked Questions

What is marketing for regulated industries?

Marketing for regulated industries is marketing in sectors such as financial services, insurance, healthcare, medical devices, and animal health, where regulators control what can be claimed, how it’s presented, who can be targeted, and how outreach is done. The fundamentals stay the same, but planning, approval, and measurement change.

How is marketing in regulated industries different from regular marketing?

Claims must be substantiated and often approved before they run, required disclosures shape creative, data and targeting have privacy limits, and outreach needs documented consent. Timelines are longer and less predictable, so campaigns are planned backward from the launch date.

Why does compliance slow down marketing, and how can teams move faster?

Review and approval add weeks or months, and rework at the end of the process adds more. Teams move faster by pre-approving modular components, involving compliance at the brief, and tracking approval cycle time to find recurring friction.

Can regulated companies still use digital advertising and retargeting?

Often yes, but conservatively. Tracking technologies on health and financial sites have drawn regulatory and legal scrutiny, so many teams rely on first-party data, consent-based programs, and server-side controls, and lean more on brand tracking and incrementality testing. Confirm your approach with privacy counsel.

Does a marketing partner need experience in my specific regulated industry?

It helps, but it’s less relevant than it looks. The rulebook is homework, and a partner who plans around review timelines, involves compliance early, and works closely with your counsel can learn it. What matters more is whether they treat compliance as a design input from the start.